Skip to main content
. 2017 Dec 19;5:117. doi: 10.3389/fcell.2017.00117

Figure 1.

Figure 1

Next-generation drug screening platform for neuropsychiatric disorders. Directed differentiation and reprogramming of patient-specific cell types into various neural cell types allows for combination culture of cell types of interest. When combined with lineage-specific reporter systems, mixed neural cultures could be screened using small-molecule libraries and the results of downstream assays correlated with the cell-type of interest.